Marylore Chenel, Ph.D.

Pharmetheus AB, France

Poster(s):

• (W0930-10-65) Bioavailability and Local Immunogenicity after Subcutaneous Administration of Therapeutic Proteins: Mechanistic Modelling within the Open Systems Pharmacology Framework
  Wednesday, October 25, 2023

  9:30 AM – 10:30 AM ET

• (M1430-10-68) Physiologically-Based Pharmacokinetic (PBPK) Modeling of Oral Absorption of 5-flucytosine to Support Development of a Sustained-Release Formulation for Treatment of Cryptococcal Meningoencephalitis
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET